Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Scheme of the test section. by Decang Lou (21439960)

“…However, when the simulated surface temperature of the vane was compared with the cooling test data, in which the vane was 3D-printed, significant deviation of the surface temperature distribution was observed. …”

Main test parameters. by Decang Lou (21439960)

“…However, when the simulated surface temperature of the vane was compared with the cooling test data, in which the vane was 3D-printed, significant deviation of the surface temperature distribution was observed. …”

Schematic of the test equipment. by Decang Lou (21439960)

“…However, when the simulated surface temperature of the vane was compared with the cooling test data, in which the vane was 3D-printed, significant deviation of the surface temperature distribution was observed. …”

Effects of compound 4f on the seizure-like response elicited by kainic acid (KA). by Naoto Arimura (416442)

Subjects:

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. by Tingting Wang (123983)

Subjects:

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. by Tingting Wang (123983)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on MDA and soluble protein content of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on photosynthetic pigments contents of HHZ and XLY900 at days 10 under saline conditions. by Yin Jie (21464235)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the root morphologies of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the dry weight of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on ion contents of HHZ and XLY900 at days 10 under saline conditions. by Yin Jie (21464235)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the growth parameters of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

Subjects:

CRISPRi interrogation of the <i>Sox10</i> ECs. by Hongjoo An (21703199)

Subjects:

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects: